Bo Yang

4.4k total citations
218 papers, 3.3k citations indexed

About

Bo Yang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bo Yang has authored 218 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 55 papers in Molecular Biology and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bo Yang's work include Cancer Immunotherapy and Biomarkers (15 papers), Immune Cell Function and Interaction (15 papers) and Acute Myeloid Leukemia Research (9 papers). Bo Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Immune Cell Function and Interaction (15 papers) and Acute Myeloid Leukemia Research (9 papers). Bo Yang collaborates with scholars based in China, United States and Philippines. Bo Yang's co-authors include Shunchang Jiao, Feng Cao, Georgette D. Kanmogne, Yi Hu, Yabin Wang, Ruili Yu, Howard E. Gendelman, Anathbandhu Chaudhuri, Yuri Persidsky and Bicheng Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bo Yang

205 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Yang China 32 1.1k 861 690 531 483 218 3.3k
Zhiwei Wang China 30 1.3k 1.2× 592 0.7× 463 0.7× 506 1.0× 754 1.6× 210 4.1k
Xīn Gào United States 31 1.2k 1.1× 919 1.1× 301 0.4× 365 0.7× 570 1.2× 187 4.0k
Joanne Lysaght Ireland 30 888 0.8× 1.2k 1.4× 858 1.2× 497 0.9× 412 0.9× 95 3.3k
Liantao Li China 27 1.2k 1.1× 869 1.0× 567 0.8× 368 0.7× 280 0.6× 115 2.9k
Li Cai China 32 1.7k 1.5× 807 0.9× 323 0.5× 802 1.5× 524 1.1× 159 3.3k
Jin Zhang China 33 1.9k 1.7× 780 0.9× 428 0.6× 627 1.2× 348 0.7× 131 3.6k
Akira Saito Japan 33 1.9k 1.7× 836 1.0× 375 0.5× 577 1.1× 814 1.7× 203 4.3k
Junling Liu China 35 1.6k 1.4× 477 0.6× 615 0.9× 446 0.8× 423 0.9× 181 4.1k

Countries citing papers authored by Bo Yang

Since Specialization
Citations

This map shows the geographic impact of Bo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Yang more than expected).

Fields of papers citing papers by Bo Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Yang. The network helps show where Bo Yang may publish in the future.

Co-authorship network of co-authors of Bo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Yang. A scholar is included among the top collaborators of Bo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Yang. Bo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yong, et al.. (2025). Design of Portable Physiotherapy Instrument With Stable Stimulation Current for Assisting in Tuina. IEEE Transactions on Consumer Electronics. 71(2). 5425–5436.
2.
Liu, Xue, Longfei Chen, Gui Chen, et al.. (2025). Amplification of cGAS-STING pathway with “single-molecule multitarget” nanoparticles for chemo-immunotherapy of ovarian cancer. Biomaterials. 323. 123434–123434.
3.
Yang, Lining, Zhang‐Bin Tan, Huijuan Wang, et al.. (2024). Przewaquinone A inhibits Angiotensin II-induced endothelial diastolic dysfunction activation of AMPK. Phytomedicine. 133. 155885–155885. 5 indexed citations
4.
Bai, Yibing, Haitao Tao, Fan Zhang, et al.. (2023). Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study. Cancer Cell International. 23(1). 224–224. 2 indexed citations
5.
6.
Yang, Bo, Chao Liu, Xiaohui Ju, et al.. (2023). A tissue specific-infection mouse model of SARS-CoV-2. Cell Discovery. 9(1). 43–43. 5 indexed citations
7.
8.
9.
Luo, Hao, Gaolei Liu, Dan Jian, et al.. (2022). Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade. Journal of Immunology Research. 2022. 1–21. 1 indexed citations
10.
Yang, Bo, Xiao Zhao, Chong Wan, et al.. (2021). Genomic profiling of Chinese patients with urothelial carcinoma. BMC Cancer. 21(1). 162–162. 6 indexed citations
11.
Zhang, Haomin, Hao Chen, Yakun Yang, et al.. (2020). Bioinformatics prediction of molecular mechanism and intervention drugs of SARS-related immune injury and their significance for COVID-19 treatment. Zhonghua weishengwuxue he mianyixue zazhi. 40(3). 165–173. 2 indexed citations
12.
Wang, Shukun, Zhigang Wang, Xiaohe Zhang, et al.. (2017). [An outbreak of paratyphoid fever in a county of Yunnan province, 2010-2011].. PubMed. 38(2). 200–204. 2 indexed citations
13.
Yang, Bo, et al.. (2016). Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome.. PubMed. 20(6). 1185–91. 13 indexed citations
14.
Yang, Bo, et al.. (2015). Obesity is a risk factor for acute mountain sickness: a prospective study in Tibet railway construction workers on Tibetan plateau.. PubMed. 19(1). 119–22. 23 indexed citations
15.
Wang, Lijie, Dan Su, Tingting Zhang, et al.. (2015). Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysis.. PubMed Central. 8(1). 650–7. 8 indexed citations
16.
Yang, Bo, Junlan Yang, Hui Liu, et al.. (2013). [Clinical paired study of comparing docetaxel plus capecitabine versus docetaxel plus epirubicin as first-line treatment in women with HER-2 negative advanced breast cancer].. PubMed. 93(18). 1397–400. 4 indexed citations
17.
Zhang, Ran, et al.. (2013). Imatinib-induced decompensated heart failure in an elderly patient with chronic myeloid leukemia: case report and literature review. Journal of Geriatric Cardiology. 9(4). 411–414. 13 indexed citations
18.
Wang, Zheng, Zhimin Xue, Weidan Pu, et al.. (2012). Comparison of first‐episode and chronic patients diagnosed with schizophrenia: symptoms and childhood trauma. Early Intervention in Psychiatry. 7(1). 23–30. 39 indexed citations
19.
20.
Zhang, Bicheng, Yafei Zhang, Juan Gao, et al.. (2011). M2-Polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics. 66(11). 1879–1886. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiwei Wang Breakdown of academic impact, for papers by Xīn Gào Breakdown of academic impact, for papers by Joanne Lysaght Breakdown of academic impact, for papers by Liantao Li Breakdown of academic impact, for papers by Li Cai Breakdown of academic impact, for papers by Jin Zhang Breakdown of academic impact, for papers by Akira Saito Breakdown of academic impact, for papers by Junling Liu
Rankless by CCL
2026